aSan Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA;
bDepartment of Psychiatry, University of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA; and
cDepartment of Neurosciences, University of California, San Diego, San Diego, CA.
Correspondence to: Rowan Saloner, MS, Predoctoral Research Fellow, Department of Psychiatry, SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, University of California, San Diego, HIV Neurobehavioral Research Program, 220 Dickinson Street, Suite B, Mail Code 8231, San Diego, CA 92103-8231 (e-mail: [email protected]).
Supported in part by awards from National Institutes of Health [the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) N01 MH2205 and HHSN271201000036C to IG; R01 MH107345 to RKH and SL; F31 AG064989 to RS; T32DA031098 to JDL; F31 AA027198 to EWP; and F31 AG067869 to LMC]. The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Government.
The authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
Poster presentation delivered at the International Neuropsychological Society (INS) Annual Conference; February 4, 2022; San Diego, CA.
